Patent Assignment
Reel/Frame 007942/0774
Assignment of Assignor's Interest
Recorded: 1996-05-07
Pages: 4
Assignors
GRYAZNOV, SERGEI M.
Executed: 1996-03-27
SCHULTZ, RONALD G.
Executed: 1996-03-27
CHEN, JER-KANG
Executed: 1996-03-27
Assignee
LYNX THERAPEUTICS, INC.
3832 BAY CENTER PLACE, HAYWARD, CALIFORNIA, 94532
Covered Property
(1)
Oligonucleotide N3'-P5' Phosphoramidates: Hybridization and Nuclease Resistance Properties
Patent:
5,599,922 →
Application:
08/214,599 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 1994
From: GRYAZNOV, SERGEI M.
To: LYNX THERAPEUTICS, INC., A CA CORP.
Reel/Frame 007071/0134 →
Corrected Assignment Recorded on Reel 7071, Frame 134 to Correct the State of Incorporation of Assignee.
Dec 2, 1994
From: GRYAZNOV, SERGEI M.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 007233/0708 →
Assignment of Assignor's Interest
Apr 23, 2002
From: LYNX THERAPEUTICS, INC.
To: GERON CORPORATION
Reel/Frame 012831/0709 →